GEn1E Lifesciences Inc.
Clinical-stage, Phase 2 company accelerating novel Precision Therapies for I&I and Rare Diseases using AI
18 employees · est. 2019 · Palo Alto, United States
GEn1E Lifesciences Inc. is the older company (2019 vs 2022); GEn1E Lifesciences Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | GEn1E Lifesciences Inc. | iniuva |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2022 |
| Headquarters | ||
| Headquarters | Palo Alto, United States | Hamburg, Germany |
| Employees | ||
| Employees | 18 larger | 5 |
| Industry | ||
| Industry | AI, Biotechnology, Health Care | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series A | Not tracked yet |
| Total Funding | ||
| Total Funding | $17.03M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 6 | Not tracked yet |
| Services | ||
| Services | Drug development from discovery to clinical trials, Development of novel therapeutics for inflammatory and rare diseases, Utilization of advanced AI platform for drug development | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with inflammatory diseases, Patients with rare diseases, Healthcare providers, Pharmaceutical industry stakeholders | Not tracked yet |
| Taxonomy | ||
| Taxonomy | AI Platform, Drug Development, Immunomodulatory Therapies, Rare Diseases, Inflammatory Diseases, Multi-target Company, Clinical-stage, Novel Therapeutics, YCombinator, Stanford-StartX, Palo Alto, Seed Capital, IND, Biotech Industry | Drug Discovery, Rare Disease Therapies, AI-Powered Platform, Pharmaceutical Development, Biotech Collaboration, Orphan Drug Market, Medical Professionals, Scientific Expertise, Protein Misfolding, Small Molecule Therapies |
| Website | ||
| Website | gen1e.com | iniuva.com |
About GEn1E Lifesciences Inc.
GEn1E Lifesciences Inc. is a clinical-stage company headquartered in the United States that is pioneering the use of AI in drug development, particularly targeting rare and inflammatory diseases. Founded in 2018, GEn1E leverages its proprietary AI platform to expedite the creation of immunomodulator...
About iniuva
iniuva is a **biotechnology** and **healthcare** startup founded in **2022** with a focus on revolutionizing drug development. Their slogan "we. fight. misfolding." reflects their dedication to addressing protein misfolding, a crucial mechanism in numerous rare diseases. Their team of medical profes...
We will tell you when either one moves
BounceWatch watches GEn1E Lifesciences Inc. and iniuva for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at GEn1E Lifesciences Inc... and iniuva — by email.
Frequently Asked Questions
Compare GEn1E Lifesciences Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at GEn1E Lifesciences Inc. on 12 Sep 2024, and iniuva on 28 Oct 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
